Vivos Inc (RDGL)

[SC8]

My guesses are either the current offering is a hedge so company can survive an IDE rejection by having sufficient funds on hand to answer any objections FDA has or, per words in the offering, they really do need more funds (and time) to get to an IDE application they can submit with confidence. Sure hoping it's the former, cuz the latter means they're pulling forecasts out of their rears that mean nothing, and couldn't even bother to issue a revised forecast as soon as they knew Aug 22 - Sept 21 wasn't going to happen. Hence why I'm saying if offering doesn't close today, we're likely looking at the latter scenario.